ArticleiScience2025
Investors demand carbon damage risk compensation in China.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Environmental disclosure and supply chain carbon leakage.iScience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As climate awareness grows, investors are integrating climate performance into their investment decision-making processes to mitigate potential risks. This paper examines the societal costs associated with the carbon footprints of publicly listed companies in China and explores whether investors demand compensation for their exposure to risks associated with investments in assets with greater carbon damages. We find a continuous rise in the carbon footprints of Chinese listed companies, with a particularly noticeable increase following the COVID-19 pandemic. The carbon damages of Chinese listed companies are sourced mainly from their value chain emissions, with significant sectoral and regional heterogeneity. Finally, we observe a carbon damage risk premium throughout entire value chain when viewed from an absolute risk perspective. Even for less perceptible relative risks, we find that listed companies with greater scaled carbon damages originating from direct and upstream value chain carbon footprints are associated with higher expected returns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.